Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells (Q39137808)

9 September 2017

title

Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells (English)

1 reference

9 September 2017

0 references

Lu Wang

1

1 reference

9 September 2017

Xiaoping Xu

2

1 reference

9 September 2017

Yi Zhang

3

1 reference

9 September 2017

Yuanqing Zhang

4

1 reference

9 September 2017

Ying Zhu

5

1 reference

9 September 2017

Jiye Shi

6

1 reference

9 September 2017

Yanhong Sun

7

1 reference

9 September 2017

Qing Huang

8

1 reference

9 September 2017

publication date

19 June 2013

1 reference

Journal of Materials Science: Materials in Medicine

9 September 2017

published in

1 reference

9 September 2017

volume

24

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

2137-2144

1 reference

Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Combined Treatment of Curcumin and Small Molecule Inhibitors Suppresses Proliferation of A549 and H1299 Human Non‐Small‐Cell Lung Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Targeting and inhibition of cell growth by an engineered dendritic nanodevice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Curcumin polymers as anticancer conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Targeting cancer cells with biotin-dendrimer conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Improving the solubility and pharmacological efficacy of curcumin by heat treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2–ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-013-4969-3

Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway

21 January 2018

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers

1 reference

12 December 2020

Anticancer potential of curcumin: preclinical and clinical studies.

1 reference

12 December 2020

Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells.

1 reference

12 December 2020

10.1007/S10856-013-4969-3

Identifiers

DOI

1 reference

9 September 2017

1 reference